Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys
08:10am, Thursday, 17'th Apr 2025
March investments totaled around $1,200, mainly in BDCs like Blue Owl Capital and Ares Capital, boosting annual dividend income by $100. Dividend income hit a new all-time record of $1,404, up 17% Y/Y
NEW YORK , April 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). Shareholders who purchased shares of ABBV
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc. (ABBV) should contact Levi & Korsinsky about pending Class Action - ABBV
07:25am, Wednesday, 16'th Apr 2025
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and want to learn about a potential recovery under the feder
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment
05:35am, Wednesday, 16'th Apr 2025
AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment are included in this Analyst Blog.
Tariffs on generic drugs will cause companies to stop making them: Former FDA Commissioner Gottlieb
10:29am, Tuesday, 15'th Apr 2025
Dr. Scott Gottlieb, former FDA Commissioner, joins 'Squawk Box' to discuss current pharmaceutical imports under investigation, moving production for branded and generic drugs elsewhere, and much more.
After Tariff Flush, a Fresh Look at AbbVie Pharma (ABBV)
09:33am, Tuesday, 15'th Apr 2025
In my 2025 Outlook, I picked AbbVie Pharmaceuticals (NYSE: ABBV) as one to watch this year. Here is what I wrote: AbbVie (ABBV) AbbVie primarily works in immunology, oncology, neuroscience, eye care,
The Zacks Analyst Blog Merck and AbbVie
07:55am, Tuesday, 15'th Apr 2025
Merck and AbbVie are included in this Analyst Blog.
NEW YORK, NY / ACCESS Newswire / April 15, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and want to learn about a potential recovery under the feder
Trump Says Pharmaceutical Tariffs Coming in Near Future
02:03pm, Monday, 14'th Apr 2025
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with repo
Trump says US pharma tariffs coming in not-too-distant future
12:26pm, Monday, 14'th Apr 2025
U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.
ABBV vs. MRK: Which Drug Giant is a Better Buy Now?
11:40am, Monday, 14'th Apr 2025
Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and want to learn about a potential recovery under the feder
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis
03:20am, Monday, 14'th Apr 2025
AbbVie's, Rinvoq and AstraZeneca's and Novartis are included in this Analyst Blog.
Final Trades: TJX, Meta, Abbvie and Taiwan Semi
02:06pm, Friday, 11'th Apr 2025
The Investment Committee give you their top stocks to watch for the second half.
NEW YORK, NY / ACCESS Newswire / April 11, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and want to learn about a potential recovery under the feder
